Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study Data from 47,768 cancer survivors and ...
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
Despite significant health disparities experienced by people with disabilities, their needs are poorly addressed and understood in health policy, research, and practice. Estimates of prevalence vary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results